SPRB vs USB · rev $4.9M vs P/E 12, rev $28.66B
Spruce Biosciences Inc (SPRB) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
SPRB currently screens at market cap $3.0M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the SPRB and USB stock pages for the full models.
Not investment advice.